Physician profile
Cindy Long
NPI 1407945405
$6,204.42
in general payments reported to CMS, 2019-2025
34 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.69 · 2020: $124 · 2021: $1,686 · 2022: $1,143 · 2023: $1,140 · 2024: $1,658 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,965 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $186 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.40 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $185.73 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,908.55 | 2022-2025 | Da Vinci Sp |
| Axonics, INC. | $1,639.80 | 2021-2024 | Bulkamid, Axonics |
| Coloplast Corp | $469.15 | 2022-2024 | Altis |
| Becton, Dickinson and Company | $392.95 | 2022-2025 | Arista Ah Flexitip, Bd Onclarity |
| Medtronic, INC. | $187.42 | 2021-2023 | Interstim |
| Abbvie INC. | $168.38 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.72 | 2020-2025 | |
| Dysis Medical, INC. | $131.80 | 2021 | |
| Channel Medsystems, INC. | $115.82 | 2022 | |
| Astellas Pharma US INC | $100.61 | 2019-2023 | Veozah |
| Meditrina | $90.81 | 2021 | |
| Boston Scientific Corporation | $78.06 | 2025 | Axonics |
| Coopersurgical, INC. | $71.27 | 2021-2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $67.04 | 2021-2025 | |
| Hologic Sales and Service, LLC | $66.41 | 2019-2024 | Aptima |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $54.74 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $53.07 | 2023-2025 | Gemtesa |
| Exeltis, USA INC. | $45.21 | 2025 | Slynd |
| Davol INC. | $44.03 | 2024 | Arista Ah Flexitip |
| Allergan, INC. | $42.73 | 2019-2020 | |
| Therapeuticsmd, INC. | $42.15 | 2020-2022 | |
| Caldera Medical, INC | $38.34 | 2022 | |
| Merck Sharp & Dohme LLC | $32.89 | 2024-2025 | Gardasil 9, Gardasil |
| Organon LLC | $32.11 | 2021-2025 | Nexplanon |
| C. R. Bard, INC. & Subsidiaries | $29.59 | 2022 | |
| Avion Pharmaceuticals | $28.24 | 2019-2021 | |
| Smith+Nephew, INC. | $24.25 | 2025 | Grafix Pl |
| Abbott Laboratories | $21.49 | 2022 | |
| Aroa Biosurgery Incorporated | $18.95 | 2024 | |
| Sage Therapeutics, LLC | $17.47 | 2024 | |
| Celgene Corporation | $16.92 | 2024 | Reblozyl |
| Roche Diagnostics Corporation | $14.57 | 2019 | |
| Minerva Surgical, INC | $13.97 | 2023 | |
| Z-Medica, LLC | $5.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.